Bio-Techne
TECH
293 hedge funds and large institutions have $3.91B invested in Bio-Techne in 2016 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 95 increasing their positions, 112 reducing their positions, and 20 closing their positions.
40% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 20
17% more call options, than puts
Call options by funds: $292K | Put options by funds: $249K
2% more funds holding
Funds holding: 288 → 293 (+5)
9% less capital invested
Capital invested by funds: $4.31B → $3.91B (-$409M)
15% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 112
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$21.1M |
| 2 |
Renaissance Technologies
New York
|
+$11.4M |
| 3 |
Millennium Management
New York
|
+$9.57M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.76M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$7.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$204M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$81M |
| 3 |
QCMC
Quantum Capital Management (California)
San Francisco,
California
|
-$13.5M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$12.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$8.07M |
TECH Hedge Fund Activity: Q3 2016 in Review
293 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q3 2016, worth a combined $3.91B — down 9.5% from $4.31B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new TECH positions and 20 closed out — a net gain of 8 holders — while 95 added to existing stakes and 112 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $21.1M. The largest seller was Macquarie Group, cutting an estimated $204M.
- 293 institutional investors held Bio-Techne (TECH) as of Q3 2016, up from 288 in Q2 2016.
- Funds reported $3.91B of Bio-Techne stock for Q3 2016, down 9.5% quarter-over-quarter.
- 28 funds opened new Bio-Techne positions in Q3 2016 and 20 closed out, a net change of +8 holders.
- The largest Bio-Techne buyer in Q3 2016 was Fred Alger Management, an estimated $21.1M added.
- The largest Bio-Techne seller in Q3 2016 was Macquarie Group, an estimated $204M sold.
Based on aggregated 13F filings for Q3 2016.